Bio-Works Technologies AB (publ)

Stockholm Stock Exchange BIOWKS.ST

Bio-Works Technologies AB (publ) Operating Income Margin for the year ending December 31, 2023: -126.25%

Bio-Works Technologies AB (publ) Operating Income Margin is -126.25% for the year ending December 31, 2023, a -10.65% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Bio-Works Technologies AB (publ) Operating Income Margin for the year ending December 31, 2022 was -114.09%, a -128.14% change year over year.
  • Bio-Works Technologies AB (publ) Operating Income Margin for the year ending December 31, 2021 was -50.01%, a 92.08% change year over year.
  • Bio-Works Technologies AB (publ) Operating Income Margin for the year ending December 31, 2020 was -631.10%, a 16.51% change year over year.
  • Bio-Works Technologies AB (publ) Operating Income Margin for the year ending December 31, 2019 was -755.91%, a -30.07% change year over year.
Key data
Date Operating Income Margin EBT Margin Net Income Margin EBITDA Margin
Market news
Loading...
SV Wall Street
Stockholm Stock Exchange: BIOWKS.ST

Bio-Works Technologies AB (publ)

CEO Ms. Lone Carlbom
IPO Date Dec. 14, 2017
Location Sweden
Headquarters Virdings allé 18
Employees 35
Sector Materials
Industries
Description

Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; OptioBio glass columns; screening kits; and size exclusion chromatography resins. The company's products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.

Similar companies

CRAD-B.ST

C-Rad AB (publ)

USD 2.87

-1.57%

GENO.ST

Genovis AB (publ.)

USD 2.25

-17.68%

IVACC.ST

Intervacc AB (publ)

USD 0.09

11.18%

CANTA.ST

Cantargia AB (publ)

USD 0.16

-4.29%

StockViz Staff

February 5, 2025

Any question? Send us an email